Which hedge funds own MXCT? MAXCYTE INC, Q2 2026 13F holders
24 tracked hedge funds disclosed a position in MXCT (MAXCYTE INC) in their Q2 2026 13F filings, worth $40.1m in total. The largest holder by portfolio weight is Vitruvian Partners LLP at 3.1% of its book. 9 opened a new position this quarter: Spark Investment Management LLC, J. Goldman & Co LP, Catalyst Funds Management Pty Ltd, Y-Intercept (Hong Kong) Ltd. 5 exited: Mink Brook Asset Management LLC, Scientech Research LLC, NINE MASTS CAPITAL Ltd.
- 24
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 9
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 5
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $1.2m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $402k
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $40.1m
- Combined value Sum of the holders' reported positions in the security.
- 1.9%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Mink Brook Asset Management LLC | 0.1% | $200k |
| Scientech Research LLC | 0.01% | $8.8k |
| NINE MASTS CAPITAL Ltd | 0.01% | $44.7k |
| Graham Capital Management, L.P. | 0.0% | $7.6k |
| D. E. Shaw & Co., Inc. | 0.0% | $141k |
Ownership over time
Who discovered MXCT first? Beta
| Nine Ten Capital Management LLC | Q3 2021 | −0.4 pts |
| Harbert Fund Advisors, LLC | Q3 2021 | −0.9 pts |
| Apis Capital Advisors, LLC | Q3 2021 | −1.6 pts |
| Stonepine Capital Management, LLC high conviction | Q1 2023 | −2.3 pts |
| Casdin Capital, LLC high conviction | Q3 2021 | −3.2 pts |
| Blue Water Life Science Advisors, LP high conviction | Q3 2022 | −3.3 pts |
| Mudita Advisors LLP high conviction | Q4 2023 | −4.7 pts |
| Vitruvian Partners LLP high conviction | Q4 2024 | −13.6 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.